Menopause Blood Test Analyzer (FSH, Estrogen, AMH)

Check More Free Tools:

• Try our Thyroid vs. Menopause Symptom Checker Tool

• Try our Breast Cancer Risk After HRT Calculator

Menopause Blood Test Analyzer: Understanding Hormonal Health During Perimenopause and Beyond

What Is Menopause?

Menopause marks the end of a woman’s reproductive years, diagnosed after 12 consecutive months without menstruation. This natural biological process involves significant hormonal shifts, particularly in follicle-stimulating hormone (FSH), estradiol (estrogen), and anti-Müllerian hormone (AMH).

The Three Stages of Menopausal Transition

1. Perimenopause: 3–10 years before menopause, marked by irregular cycles and hormonal fluctuations

2. Menopause: Final menstrual period confirmed after 12 months of amenorrhea

3. Postmenopause: Life phase following menopause

Key Hormones Analyzed in Menopause Blood Tests

1. Follicle-Stimulating Hormone (FSH)

Role: Regulates ovarian follicle development and estrogen production
Normal Ranges:

StageFSH Levels (mIU/mL)Reproductive3–10Perimenopause10–25Postmenopause>25

Clinical Significance: Rising FSH levels indicate declining ovarian reserve.

2. Estradiol (Primary Estrogen)

Role: Maintains reproductive tissues and bone density
Normal Ranges:

StageEstradiol (pg/mL)Reproductive30–400Perimenopause20–100Postmenopause<30

Clinical Significance: Low levels correlate with menopausal symptoms like hot flashes.

3. Anti-Müllerian Hormone (AMH)

Role: Indicates ovarian reserve and remaining egg supply
Normal Ranges:

Age GroupAMH Levels (ng/mL)<34 years1.5–4.035–40 years1.0–3.0Perimenopause<1.0

Clinical Significance: AMH <0.5 ng/mL suggests imminent menopause.

How the Menopause Blood Test Analyzer Works

Input Parameters Measured

• FSH Levels (with unit conversion for global standards)

• Estradiol Concentration

• AMH Values

• Menstrual cycle status (regular/irregular/absent)

• Patient demographics (age, gender)

Algorithm Behind the Analysis

The calculator uses evidence-based thresholds:

1. FSH Scoring:

   • 25 mIU/mL → High likelihood of menopause (2 points)

   • 15–25 mIU/mL → Peri-menopausal (1 point)

2. Estradiol Scoring:

   • <30 pg/mL → Postmenopausal (2 points)

   • 30–50 pg/mL → Transition phase (1 point)

3. AMH Scoring:

   • <0.5 ng/mL → Low ovarian reserve (2 points)

   • 0.5–1.0 ng/mL → Declining reserve (1 point)

Total Score Interpretation:

• 0–2 → Premenopausal (Green)

• 3–5 → Perimenopausal (Yellow)

• 6–8 → Postmenopausal (Red)

Interpreting Your Results

Visual Risk Meter

The tool displays a color-coded progress bar:

• 🟢 Green: Normal hormone levels

• 🟡 Yellow: Early transition phase

• 🔴 Red: Likely postmenopausal status

Personalized Recommendations

Based on results, users receive actionable guidance:

• Lifestyle modifications (e.g., calcium intake for bone health)

• When to consult a gynecologist

• Potential need for hormone replacement therapy (HRT)

Why Monitor Menopausal Hormones?

Early Detection of Health Risks

• Osteoporosis: Low estrogen accelerates bone loss

• Cardiovascular Disease: Estrogen decline increases LDL cholesterol

• Cognitive Changes: Hormonal shifts may impact memory

Fertility Planning

AMH levels help predict:

• Remaining reproductive window

• IVF success probabilities

Benefits of Using DoseWay’s Analyzer

1. Instant Analysis: No lab wait times

2. PDF Report: Downloadable for physician consultations

3. Data Privacy: HIPAA-compliant local processing

4. Global Compatibility: Unit conversions for international users